Supporting UCLA faculty in advancing global health research

The DGSOM Global Health Program (GHP), in collaboration with International Health Services, is pleased to offer a Global Health Seed Grant Program, launched in 2019, to (1) support faculty involved in multidisciplinary global health research in low- and middle-income countries, (2) establish or further build long-term global research partnerships that address pressing health questions relevant to the local setting, and (3) strengthen the capacity of early-career investigators at UCLA and global partner sites.

The eleven awarded teams to date are using funds to collaborate with researchers and trainees in Mozambique, Peru, Thailand, Togo, Uganda, and Vietnam, to launch initiatives focused on improving health and advancing health equity.

List of projects awarded in 2019 through 2024:

  • 2020/2021
    • A study of an adapted approach to HIV-exposed infant follow-up using fever as a criterion for testing to improve timely diagnosis and antiretroviral therapy in Mozambique
    • Adapt the TransAction intervention for trans women with/at risk of HIV in Vietnam
  • 2021/2022
    • The use of long-term preserved corneas for perforated corneal ulcer in Vietnam
    • A new algorithm to detect critical congenital heart disease at different altitudes in Peru
    • Mixed-methods study to collect data about what affects adherence and engagement in care among hypertensive adults in Thailand

  • 2022/2023
    • Feasibility of Antenatal Syphilis and HIV Point of Care Testing to Prevent Mother-to-Child Transmission in Uganda
  • 2023/2024
    • Psychiatric comorbidity and recovery outcomes among STAR-OM patients in Vietnam
    • Optimization of mHealth follow-up in Cameroon: A multi-methods approach

  • 2024/2025
    • Pulmonary and Economic Outcomes of Treated Tuberculosis in a TB-endemic Population in Peru
    • Forest Conservation & Human Health at the Intersection of Community Based Participatory Research & Ethnography in Togo
    • Development of a clinical decision support tool to address the epilepsy treatment gap in Uganda: A pilot study

For this upcoming year, awards are available at two funding levels: (1) up to $50,000 and (2) up to $15,000 for a period of one year.  We anticipate awarding multiple grants this year.

  • Principal Investigator (PI): Must be a UCLA faculty member. Adjunct faculty, fellows, and residents are not eligible to serve as PI, though they may be listed as co-investigators or early career investigators.
  • DGSOM Affiliation: At least one investigator must hold a faculty appointment in the David Geffen School of Medicine (DGSOM).
  • Team Composition: Projects must be led by multidisciplinary teams. This can mean:
    • Two different scientific disciplines (e.g., clinical + social science), or
    • Two distinct clinical specialties (e.g., internal medicine + surgery).
    • Collaboration across UCLA schools is strongly encouraged (e.g., DGSOM + Fielding School of Public Health).
  • Global Partnership: A lead investigator from the global partner site must be included as Co-PI. Proposed work must take place in a low- or middle-income country, as defined by the World Bank.
  • Early Career Investigators: Each project must include:
    • At least one early career investigator from UCLA, and
    • At least one early career investigator from the global partner site.
      These roles are intended to provide meaningful research experience and build capacity at both institutions. A mentorship plan must be included.
  • IRB Approvals: Not required at the time of submission. For funded awards, IRB approval from both UCLA and the relevant regulatory agency at the global partner site will be required before funds are released.

 Ineligible Proposals:

  • Projects focused solely on training exchange (without a clear capacity-building plan for early career investigators)
  • Projects based primarily in UCLA or Los Angeles laboratories (unless directly tied to building lab capacity at the partner site)
  • Repeat proposals by the same PI and partner site in consecutive years

    For complete details, please review the Full Eligibility and Ineligibility Criteria

Letter of Intent (LOI) – Due October 10, 2025 
Applicants must submit an LOI via Qualtrics including:

  • UCLA PI (faculty) information (name, degree(s), department, contact info)
  • Global site Co-PI (name, degree(s), affiliation, contact info)
  • Names and affiliations of all co-investigators
  • At least one early career investigator from UCLA and one from the global site (with explanation of eligibility)
  • Global partner name and brief description of site
  • Specific aims of the project
  • Funding level requested ($15,000 or $50,000)

Full Proposal (by invitation only) – Due December 10, 2025
Invited applicants must submit:

  1. Cover page and checklist (template provided)
  2. Research proposal (max 4 pages, Arial 11-pt, ½-inch margins), including:
    • Specific aims
    • Significance
    • Approach/methodology
    • Global health impact (partnership, collaboration to date, mentorship/training plan for early career investigators)
    • Project timeline
  3. Biosketches for PI and all co-investigators (NIH format; CV allowed for early career investigators)
  4. Itemized budget and justification
  5. Letter(s) of support from global site Co-PI and key collaborators
  6. Letter of support from UCLA Division Chief or Department Chair confirming PI’s standing and support

2026-27 Application process and timeline

For complete details, please review the Request for Applications

  • Step 1: Letter of Intent
    Due: Friday, October 10, 2025 – 5:00 PM PST (via Qualtrics)
    All applicants must submit a Letter of Intent before submitting a full proposal.
  • Step 2: Notification to Submit Full Proposal
    Week of November 10, 2025
    Applicants invited to submit a full proposal will be notified by email.
    Please review the [Scoring Criteria for Reviewers] and [FAQs] when preparing your application.
  • Step 3: Full Proposal Submission
    Due: Thursday, December 10, 2025 by 5:00 PM PST
    Resources: [Application Package] | [Budget Justification (Mednet login required)]
  • Step 4: Award Announcement
    Early-to-mid March 2026
  • Step 5: Award Period
    May 2026 – June 30, 2027
    (contingent on UCLA and global partner site IRB approvals)

Alert

The terms of this award may be amended should University funding be significantly compromised due to unforeseen circumstances.